Sheaff Brock Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $843K | Sell |
9,386
-1,369
| -13% | -$123K | 0.08% | 188 |
|
|
2024
Q4 | $859K | Sell |
10,755
-47
| -0.4% | -$4.07K | 0.07% | 182 |
|
|
2024
Q3 | $973K | Buy |
10,802
+84
| +0.8% | +$7.07K | 0.09% | 174 |
|
|
2024
Q2 | $844K | Sell |
10,718
-1,695
| -14% | -$139K | 0.08% | 184 |
|
|
2024
Q1 | $1.08M | Sell |
12,413
-1,287
| -9% | -$110K | 0.07% | 176 |
|
|
2023
Q4 | $1.13M | Buy |
13,700
+681
| +5% | +$51.9K | 0.09% | 161 |
|
|
2023
Q3 | $1.02M | Buy |
13,019
+18
| +0.1% | +$1.51K | 0.09% | 162 |
|
|
2023
Q2 | $1.15M | Sell |
13,001
-477
| -4% | -$41.1K | 0.1% | 148 |
|
|
2023
Q1 | $1.09M | Sell |
13,478
-79
| -0.6% | -$6.44K | 0.1% | 159 |
|
|
2022
Q4 | $1.05M | Buy |
13,557
+122
| +0.9% | +$9.89K | 0.1% | 159 |
|
|
2022
Q3 | $1.08M | Buy |
13,435
+2,153
| +19% | +$193K | 0.12% | 142 |
|
|
2022
Q2 | $1.01M | Sell |
11,282
-50
| -0.4% | -$5.07K | 0.08% | 154 |
|
|
2022
Q1 | $1.26M | Sell |
11,332
-40,982
| -78% | -$4.33M | 0.09% | 153 |
|
|
2021
Q4 | $5.41M | Buy |
52,314
+2,128
| +4% | +$246K | 0.36% | 54 |
|
|
2021
Q3 | $6.29M | Buy |
50,186
+411
| +0.8% | +$53.2K | 0.46% | 43 |
|
|
2021
Q2 | $6.18M | Buy |
49,775
+1,331
| +3% | +$167K | 0.44% | 41 |
|
|
2021
Q1 | $5.72M | Buy |
48,444
+14
| +0% | +$1.64K | 0.45% | 44 |
|
|
2020
Q4 | $5.67M | Sell |
48,430
-34
| -0.1% | -$3.74K | 0.48% | 41 |
|
|
2020
Q3 | $5.04M | Sell |
48,464
-85
| -0.2% | -$8.54K | 0.46% | 41 |
|
|
2020
Q2 | $4.45M | Buy |
48,549
+37,157
| +326% | +$3.56M | 0.44% | 42 |
|
|
2020
Q1 | $1.03M | Sell |
11,392
-138
| -1% | -$14.7K | 0.14% | 95 |
|
|
2019
Q4 | $1.31M | Buy |
11,530
+982
| +9% | +$108K | 0.13% | 107 |
|
|
2019
Q3 | $1.15M | Sell |
10,548
-14,215
| -57% | -$1.48M | 0.12% | 119 |
|
|
2019
Q2 | $2.41M | Sell |
24,763
-22
| -0.1% | -$2.01K | 0.26% | 69 |
|
|
2019
Q1 | $2.26M | Sell |
24,785
-183
| -0.7% | -$16.4K | 0.27% | 76 |
|
|
2018
Q4 | $2.27M | Buy |
24,968
+58
| +0.2% | +$5.42K | 0.36% | 67 |
|
|
2018
Q3 | $2.45M | Sell |
24,910
-53
| -0.2% | -$4.9K | 0.23% | 76 |
|
|
2018
Q2 | $2.14M | Sell |
24,963
-380
| -1% | -$31.7K | 0.21% | 80 |
|
|
2018
Q1 | $2.03M | Sell |
25,343
-3,187
| -11% | -$263K | 0.21% | 77 |
|
|
2017
Q4 | $2.3M | Buy |
28,530
+214
| +0.8% | +$17.1K | 0.3% | 73 |
|
|
2017
Q3 | $2.2M | Buy |
28,316
+32
| +0.1% | +$2.66K | 0.29% | 75 |
|
|
2017
Q2 | $2.51M | Buy |
28,284
+72
| +0.3% | +$6.07K | 0.33% | 64 |
|
|
2017
Q1 | $2.27M | Sell |
28,212
-324
| -1% | -$25.3K | 0.3% | 73 |
|
|
2016
Q4 | $2.03M | Buy |
28,536
+268
| +0.9% | +$21.1K | 0.26% | 83 |
|
|
2016
Q3 | $2.44M | Sell |
28,268
-935
| -3% | -$81.5K | 0.33% | 70 |
|
|
2016
Q2 | $2.53M | Sell |
29,203
-37
| -0.1% | -$2.99K | 0.32% | 72 |
|
|
2016
Q1 | $2.19M | Sell |
29,240
-87
| -0.3% | -$6.55K | 0.27% | 78 |
|
|
2015
Q4 | $2.26M | Buy |
+29,327
| New | +$2.21M | 0.26% | 95 |
|
Other funds holding MDT
Sheaff Brock Investment Advisors's MDT Position: Q1 2025 in Review
Sheaff Brock Investment Advisors reduced its Medtronic (MDT) stake by 13% in Q1 2025, selling an estimated $123K and leaving 9,386 shares worth $843K. The position accounts for 0.08% of the portfolio, ranked #188.
Sheaff Brock Investment Advisors first reported a position in MDT in Q4 2015 and has held it in 38 quarters since. The position peaked at $6.29M in Q3 2021. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.
- Sheaff Brock Investment Advisors held 9,386 shares of Medtronic worth $843K as of Q1 2025.
- Sheaff Brock Investment Advisors sold 1,369 Medtronic shares in Q1 2025, an estimated $123K.
- Medtronic made up 0.08% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #188 holding.
- Sheaff Brock Investment Advisors first reported a position in Medtronic in Q4 2015 and has held it in 38 quarters since.
- Sheaff Brock Investment Advisors's Medtronic position peaked at $6.29M in Q3 2021.
- 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.
Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.